Official UK procurement notice
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
Authority: Western Health and Social Care Trust (Central government)
What is being bought
Published requirement descriptionSupply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 10 Nov 2025, 15:58 GMT
- Last source update
- 8 Dec 2025, 12:50 GMT
- Authority reference
WT2025-07- FTS notice number
2025/S 000-080590- Latest notice
- Contract details notice (UK7)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05ddfeFind a Tender
- Why no open competition
- Single Suppliers Intellectual Property Exclusive Rights
- Published justification
Section 41 of the PA2023, permits a direct award in specific cases. Schedule 5 of the PA2023 sets out justifications for direct award - this particular supplier having intellectual property rights or other exclusive rights, only this supplier can supply the goods, services or works required, and
(b)there are no reasonable alternatives to those goods, services or works
How it was run
Official notice- Submission deadline
- —
Timeline
19 Nov 2025 → 8 Dec 2025 · 2 dates- Standstill ends337 days ago19 Nov 2025, 23:59 GMT
- Notice published318 days ago8 Dec 2025, 12:50 GMT
Notice history
4 events · 3 releases on Find a Tender · since 10 Nov 2025- Transparency notice published10 Nov 2025, 15:58 GMTUK5
- Contract award notice published10 Nov 2025, 16:36 GMTUK6
- Contract signature expected28 Nov 2025, 23:59 GMTscheduled
- Contract details notice published8 Dec 2025, 12:50 GMTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS UK LIMITEDWT2025-07 - SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection1 Dec 2025 – 30 Nov 2028 | £4,638,166 | 10 Nov 2025 | Awarded |
Contracts
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection · NOVARTIS PHARMACEUTICALS UK LIMITED
- Signed
- 14 Nov 2025
- Value
- £4,638,166
- Period
- 1 Dec 2025 – 30 Nov 2028
- Status
- active
3 agreed KPIs: Price · Accuracy of Order · Product Availability
- Price
- Accuracy of Order
- Product Availability
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- NOVARTIS PHARMACEUTICALS UK LIMITEDAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender